L N Voruganti
Affiliation: University of Western Ontario
- Cannabis induced dopamine release: an in-vivo SPECT studyL N Voruganti
Institute of Medical Science, University of Toronto, Toronto, ON, Canada
Psychiatry Res 107:173-7. 2001....
- Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imagingL Voruganti
Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
Neuropsychopharmacology 25:642-50. 2001....
- Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophreniaLakshmi N P Voruganti
Institute of Medical Science, University of Toronto, Toronto, Canada
Schizophr Res 56:37-46. 2002....
- Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic studyL Voruganti
Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
Schizophr Res 57:201-8. 2002..We examined the long-term consequences of switching patients from conventional to novel antipsychotic drugs, from a patient's perspective...
- Intervention research in psychosis: issues related to the assessment of quality of lifeA G Awad
Mental Health Program, Humber River Regional Hospital, Toronto, Ontario, Canada
Schizophr Bull 26:557-64. 2000..Unless these issues are adequately clarified and resolved, the recent heightened interest in the concept of quality of life may fade away, and that would be a missed opportunity in the mental health field...
- Impact of atypical antipsychotics on quality of life in patients with schizophreniaA George Awad
Institute of Medical Science and Department of Psychiatry, University of Toronto, Humber River Regional Hospital, Toronto, Ontario, Canada
CNS Drugs 18:877-93. 2004....
- New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?A George Awad
University of Toronto, Institute of Medical Science, Ontario
Can J Psychiatry 49:297-302. 2004..This overview reviews the impact of second-generation antipsychotics on less frequently researched outcomes such as medication-adherence behaviour, quality of life, and subjective tolerability in patients with schizophrenia...
- Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scaleA George Awad
Department of Psychiatry, Humber Regional Hospital, 1575 Keele Street, Toronto M6M 3Z4, Canada
Schizophr Res 70:63-7. 2004....
- What's in a name? The evolution of the nomenclature of antipsychotic drugsCaroline King
Department of Psychiatry, University of Western Ontario, London, Ont
J Psychiatry Neurosci 27:168-75. 2002..This article examines the origins, progenitors and usage of the word "antipsychotic" and explores its ramifications...
- Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT studyLakshmi N P Voruganti
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, and Humber River Regional Hospital, Toronto, Ontario, Canada
Schizophr Res 88:179-86. 2006....
- Going beyond: an adventure- and recreation-based group intervention promotes well-being and weight loss in schizophreniaLakshmi N P Voruganti
St Joseph s Healthcare, Hamilton, Ontario
Can J Psychiatry 51:575-80. 2006..To undertake a preliminary study to assess the feasibility of clinical implementation and evaluate the effectiveness of a novel adventure- and recreation-based group intervention in the rehabilitation of individuals with schizophrenia...
- The burden of schizophrenia on caregivers: a reviewA George Awad
Department of Psychiatry and the Institute of Medical Science, University of Toronto, Humber River Regional Hospital, Toronto, Ontario, M6M 3Z4, Canada
Pharmacoeconomics 26:149-62. 2008....